ShockWave Medical Inc.

NASDAQ: SWAV · Real-Time Price · USD
334.75
-0.08 (-0.02%)
At close: May 30, 2024, 10:00 PM

ShockWave Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
730.23M 489.73M 237.15M
Cost of Revenue
95.39M 65M 41.44M
Gross Profit
634.84M 424.74M 195.71M
Operating Income
165.99M 124.13M -871K
Interest Income
n/a 1.89M 1.1M
Pretax Income
174.28M 120.83M -8.84M
Net Income
147.28M 216M -9.14M
Selling & General & Admin
330.1M 218.92M 146.03M
Research & Development
145.65M 81.68M 50.54M
Other Expenses
23.96M 1.05M -582K
Operating Expenses
468.85M 300.6M 196.58M
Interest Expense
6.2M 1.89M 1.1M
Selling & Marketing Expenses
234.84M 162M 111.29M
Cost & Expenses
564.24M 365.6M 238.02M
Income Tax Expense
27M -95.17M 301K
Shares Outstanding (Basic)
36.71M 35.9M 35.1M
Shares Outstanding (Diluted)
38.21M 37.88M 35.1M
EPS (Basic)
4.01 6.02 -0.26
EPS (Diluted)
3.85 5.70 -0.26
EBITDA
176.35M 127.57M -871K
EBIT
180.48M 122.71M -7.74M
Depreciation & Amortization
10.36M -1.42M -6.87M